Evidence map›Paper›PMID 41353252›Full record

ArticleNPJ genomic medicine2025

Clinical characteristics of EYS-associated retinal dystrophy in 291 Japanese patients.

Yoshito Koyanagi, Yusuke Murakami, Taro Kominami, Masatoshi Fukushima, Kensuke Goto, Satoshi Yokota, Kei Mizobuchi, Go Mawatari, Kaoruko Torii, Yuji Inoue and 18 more

Abstract read
In one paragraph

Article in NPJ genomic medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Genetic characterization of inherited retinal dystrophy in a Northwestern Chinese cohort: A single-center study over a 5-year period in Shaanxi, China.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Yoshito KoyanagiDepartment of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Yusuke MurakamiDepartment of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Taro KominamiDepartment of Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Masatoshi FukushimaDepartment of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Kensuke GotoDepartment of Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Satoshi YokotaDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.
Kei MizobuchiDepartment of Ophthalmology, The Jikei University School of Medicine, Tokyo, Japan.
Go MawatariDepartment of Ophthalmology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Kaoruko ToriiDepartment of Ophthalmology, Hamamatsu University School of Medicine, Shizuoka, Japan.
Yuji InoueDepartment of Ophthalmology, School of Medicine, Teikyo University, Itabashi, Tokyo, Japan.
Junya OtaDepartment of Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Daishi OkudaDepartment of Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Kohta FujiwaraDepartment of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Hanayo YamagaDepartment of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Takahiro HisaiDepartment of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Mikiko EndoLaboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Hanae IijimaLaboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Tomoko KaidaMiyata Eye Hospital, Miyazaki, Japan.
Kazunori MiyataMiyata Eye Hospital, Miyazaki, Japan.
Shuji NakazakiMiyazaki Chuoh Eye Hospital, Miyazaki, Japan.
Takaaki HayashiDepartment of Ophthalmology, The Jikei University School of Medicine, Tokyo, Japan.
Yasuhiko HiramiDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.
Masato AkiyamaDepartment of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Chikashi TeraoLaboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Yukihide MomozawaLaboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Koh-Hei SonodaDepartment of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Koji M NishiguchiDepartment of Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yasuhiro IkedaDepartment of Ophthalmology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan. ymocl@med.miyazaki-u.ac.jp.

Funding

Japan Agency for Medical Research and Development 24ek0109707h0001Japan Agency for Medical Research and Development JP23ek0109632Japan Society for the Promotion of Science 20K23005Japan Society for the Promotion of Science 23K27750Japan Society for the Promotion of Science 24K12771
6 · The paper itself

Abstract

Eyes shut homolog (EYS) is the most common autosomal recessive causative gene of inherited retinal dystrophy (IRD) in the Japanese population, yet genotype-phenotype correlation data remain limited. We analyzed 291 probands (141 males, 150 females) with IRD caused by EYS (EYS-RD) from eight Japanese facilities. Clinical variables included age at onset, initial symptoms, best-corrected visual acuity (BCVA), and its progression alongside genotype information. Mean onset was 25.8 ± 14.9 years, most often night blindness (67.0%), and rod-cone dystrophy was observed in 95.9%. Initial BCVA averaged 0.34 ± 0.56 logMAR, declining 0.03 ± 0.06 logMAR/year, with low vision and blindness estimated at 48.4 and 73.6 years, respectively. Three major East Asian-specific pathogenic variants (S1653fs, Y2935X, and G843E) accounted for 88.7% of all cases. S1653fs homozygotes showed the earliest onset (mean, 18.4 years). These findings support the potential of genetic testing for personalized medicine tailored to population characteristics.

Identifiers

PMID41353252
PMCPMC12780129

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.